Literature DB >> 2597556

Laboratory evaluation of a double lumen catheter for venovenous neonatal ECMO.

T Otsu1, S I Merz, K A Hultquist, R J Attorri, H L Anderson, D E Scheffler, A Ahmad, R H Bartlett.   

Abstract

The authors designed and tested a 14F outside diameter thin-walled double lumen catheter (DLC) for neonatal venovenous (VV) extracorporeal membrane oxygenation (ECMO). In vitro tests with water and dye solution showed capacity of the drainage lumen was 1,096 ml/min at 100 cm siphon, and pressure drop across the perfusion lumen was 300 mmHg at 500 ml/min flow. Recirculation at 500 ml/min flow ranged from 5 to 29%, depending upon simulated cardiac output. The highest serum hemoglobin during 12 hour 400 ml/min flow VV bypass in five dogs was 49 mg/dl. Typical oxygen transport in four dogs was 25 cc/min at 400 ml/min flow. This catheter is well suited for clinical VV ECMO in neonates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2597556     DOI: 10.1097/00002480-198907000-00156

Source DB:  PubMed          Journal:  ASAIO Trans        ISSN: 0889-7190


  4 in total

1.  Efficacy of Flow Monitoring During ECMO.

Authors:  Aditya Badheka; Sara E Stucker; Joseph W Turek; Madhavan L Raghavan
Journal:  ASAIO J       Date:  2017 Jul/Aug       Impact factor: 2.872

2.  Newborn extracorporeal lung assist using a novel double lumen catheter and a heparin-bonded membrane lung.

Authors:  K Tsuno; H Terasaki; T Otsu; T Okamoto; Y Sakanashi; T Morioka
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 3.  Overview of the bicaval dual lumen cannula.

Authors:  Vanessa Marie Bazan; Evan Michael Taylor; Tyler Michael Gunn; Joseph Bertram Zwischenberger
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-03-31

4.  Complications and mortality of venovenous extracorporeal membrane oxygenation in the treatment of neonatal respiratory failure: a systematic review and meta-analysis.

Authors:  Jing Xiong; Li Zhang; Lei Bao
Journal:  BMC Pulm Med       Date:  2020-05-07       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.